CA2344145A1 - Inventory control - Google Patents
Inventory control Download PDFInfo
- Publication number
- CA2344145A1 CA2344145A1 CA002344145A CA2344145A CA2344145A1 CA 2344145 A1 CA2344145 A1 CA 2344145A1 CA 002344145 A CA002344145 A CA 002344145A CA 2344145 A CA2344145 A CA 2344145A CA 2344145 A1 CA2344145 A1 CA 2344145A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- library
- interest
- support
- population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K19/00—Record carriers for use with machines and with at least a part designed to carry digital markings
- G06K19/06—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
- G06K19/06009—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code with optically detectable marking
- G06K19/06046—Constructional details
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S420/00—Alloys or metallic compositions
- Y10S420/903—Semiconductive
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Nanotechnology (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- Theoretical Computer Science (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Luminescent Compositions (AREA)
Abstract
A novel encoding system, compositions for use therein and methods for determining the source, location and/or identity of a particular item or component of interest is provided. In particular, the present invention utilizes a collection of one or more sizes of populations of semiconductor nanocrystals having characteristic spectral emissions, to "track" the source or location of an item of interest or to identify a particular item of interest. The semiconductor nanocrystals used in the inventive compositions can be selected to emit a desired wavelength to produce a characteristic spectral emission in narrow spectral widths, and with a symmetric, nearly Gaussian line shape, by changing the composition and size of the semiconductor nanocrystal. Additionally, the intensity of the emission at a particular characteristic wavelength can also be varied, thus enabling the use of binary or higher order encoding schemes.
Claims (30)
1. A composition comprising of one or more populations of member semiconductor nanocrystals, wherein each population has a distinct characteristic spectral emission.
2. A composition comprising:
(a) a support; and (b) the composition of one or more populations of member semiconductor nanocrystals of claim 1 associated with the support, to provide a support-nanocrystal conjugate.
(a) a support; and (b) the composition of one or more populations of member semiconductor nanocrystals of claim 1 associated with the support, to provide a support-nanocrystal conjugate.
3. A composition comprising:
(a) a composition comprising of one or more populations of member semiconductor nanocrystals, wherein each population has a distinct characteristic spectral emission; and (b) an item of interest associated with the composition, to provide a nanocrystal-item of interest conjugate.
(a) a composition comprising of one or more populations of member semiconductor nanocrystals, wherein each population has a distinct characteristic spectral emission; and (b) an item of interest associated with the composition, to provide a nanocrystal-item of interest conjugate.
4. The composition of claim 2, further comprising a item of interest associated with the support-nanocrystal conjugate.
5. The composition of claim 1, 2, 3 or 4, wherein the characteristic spectral emission is a wavelength of emitted light, an intensity of emitted light, or both an intensity of emitted light and a wavelength of emitted light.
6. The composition of claim 2, 3 or 4, wherein the association is selected from the group consisting of covalent, hydrophobic, van der Waals forces, adsorption, and interaction between first and second members of a binding pair.
7. The composition of claim 6, wherein the association is the interaction between first and second members of a binding pair.
8. The composition of claim 7, wherein the first member of the binding pair comprises an antibody or binding portion or fragment thereof, an antigen, avidin, streptavidin, or biotin.
9. The composition of claim 2 or 4, wherein the support comprises cellulose, polystyrene, polyacrylamide, silica gels, polystyrene cross-linked with divinylbenzene, latex, dimethylacrylamide, dimethylacrylamide cross-linked with N,N'-bis-acryloyl ethylene diamine, low molecular weight non-cross-linked polystyrene, polyacrylate, polyimide, polyethylene, polyvinyl, poly-diacetylene, polyphenylene-vinylene, polypeptide, polysaccharide, polysulfone, polypyrrole, polyimidazole, polythiophene, polyether, epoxies, siloxane, polyphosphate, hydrogel, agarose, silica, glass, grafted co-polymers, pore-glass and glass coated with a hydrophobic polymer.
10. The composition of claim 2 or 4, wherein the support is in the form of a bead, a pellet, a disk, a capillary, a hollow fiber, a needle or a solid fiber.
11. The composition of claim 3 or 4, wherein said item of interest is selected from the group consisting of a consumer product, an identification tag, a security tag, a chemical compound, a biomolecule, a fluid and a solid.
12. The composition of claim 3 or 4, wherein the item of interest is an oligonucleotide, a polypeptide, or a sugar moiety.
13. The composition of claim 1, 2, 3 or 4, wherein each nanocrystal member of each population of the collection comprises:
a core comprising a first semiconductor material; and a shell layer overcoating the core, the shell comprising a second semiconductor material having a band gap greater than that of the core, wherein the first semiconductor material and the second semiconductor material are the same or different.
a core comprising a first semiconductor material; and a shell layer overcoating the core, the shell comprising a second semiconductor material having a band gap greater than that of the core, wherein the first semiconductor material and the second semiconductor material are the same or different.
14. The composition of claim 13, wherein the core is a Group II-VI, Group III-V or Group IV semiconductor.
15. The composition of claim 13, wherein the core comprises CdS, CdSe, CdTe, ZnS, ZnSe, ZnTe, MgTe, GaAs, GaP, GaSb, GaN, HgS, HgSe, HgTe, InAs, InP, InSb, InN, A1As, A1P, A1Sb, A1S, PbS, PbSe, Ge, Si, an alloy thereof, or a mixture thereof.
16. The composition of claim 15, wherein the shell comprises ZnO, ZnS, ZnSe, ZnTe, CdO, CdS, CdSe, CdTe, MgS, MgSe, GaAs, GaN, GaP, GaAs, GaSb, HgO, HgS, HgSe, HgTe, InAs, InN, InP, InSb, A1As, A1N, A1P, A1Sb, an alloy thereof, or a mixture thereof.
17. The composition of claim 13, wherein the core is CdSe and the shell is ZnS.
18. The composition of claim 13, wherein the core is a member of a monodisperse particle population.
19. The composition of claim 18, wherein the monodisperse particle population is characterized in that when irradiated the population emits light in a spectral range of about 40-60 nm full width at half maximum (FWHM).
20. The composition of claim 19, wherein the monodisperse particle population is characterized in that when irradiated the population emits light in a spectral range of about 12-15nm full width at half maximum (FWHM).
21. The composition of claim 18, wherein the monodisperse particle population is characterized in that it exhibits no more than about a 10% rms deviation in the diameter of the core.
22. The composition of claim 21, wherein the monodisperse particle population is characterized in that it exhibits no more than about 5% rms deviation in the diameter of the core.
23. A method for identifying an item of interest, comprising:
(a) providing the composition of claim 1 or 2;
(b) associating the composition with the item of interest to provide an encoded item of interest;
(c) subjecting the encoded item of interest to a light source to obtain the characteristic spectral emission; and (d) correlating said spectral emission with the identity of said item of interest.
(a) providing the composition of claim 1 or 2;
(b) associating the composition with the item of interest to provide an encoded item of interest;
(c) subjecting the encoded item of interest to a light source to obtain the characteristic spectral emission; and (d) correlating said spectral emission with the identity of said item of interest.
24. A library of compounds, wherein each compound in the library is bound to an individual support, each support having associated therewith one or more populations of semiconductor nanocrystals, each population having a distinct characteristic spectral emissions.
25. The library of claim 24, wherein each nanocrystal member comprises:
a core comprising a first semiconductor material; and a shell layer overcoating the core, the shell comprising a second semiconductor material having a band gap greater than that of the core, wherein the first semiconductor material and the second semiconductor material are the same or different.
a core comprising a first semiconductor material; and a shell layer overcoating the core, the shell comprising a second semiconductor material having a band gap greater than that of the core, wherein the first semiconductor material and the second semiconductor material are the same or different.
26. The library of claim 25, wherein the characteristic spectral emission is a wavelength of emitted light, an intensity of emitted light, or both a wavelength and an intensity of emitted light.
27. A method for identifying a compound having a characteristic of interest comprising:
(a) providing a library of member compounds, wherein each member of said library of compounds is attached to a support, and wherein each support also has attached thereto or embedded therein one or more populations of semiconductor nanocrystals each population having distinct characteristic spectral emissions;
(b) testing each member of said library of compounds to identify compounds having a characteristic of interest;
(c) subjecting each support to a light source to obtain the characteristic spectral emission; and (d) correlating the spectral emission with the identity of the compound having the characteristic of interest.
(a) providing a library of member compounds, wherein each member of said library of compounds is attached to a support, and wherein each support also has attached thereto or embedded therein one or more populations of semiconductor nanocrystals each population having distinct characteristic spectral emissions;
(b) testing each member of said library of compounds to identify compounds having a characteristic of interest;
(c) subjecting each support to a light source to obtain the characteristic spectral emission; and (d) correlating the spectral emission with the identity of the compound having the characteristic of interest.
28. A method for identifying a molecule having a characteristic of interest comprising:
providing a first library of one or more member molecules, wherein each member of said first library is attached to a first support having attached thereto or embedded therein one or more first populations of semiconductor nanocrystals, each first population having a distinct characteristic first spectral emission;
providing a second library of one or more member molecules, wherein each member of said second library is attached to a second support having attached thereto or embedded therein one or more second populations of semiconductor nanocrystals, each second population having a distinct characteristic second spectral emission, and wherein the second spectral emission is distinct from the first spectral emission;
contacting said first library of molecules with said second library of molecules observing the first and second spectral emissions, wherein said first and second spectral emissions provide information about which of the molecules from the second library of molecules are associated with said first library of molecules, and provides information about the identity of the molecule from said first library of molecules.
providing a first library of one or more member molecules, wherein each member of said first library is attached to a first support having attached thereto or embedded therein one or more first populations of semiconductor nanocrystals, each first population having a distinct characteristic first spectral emission;
providing a second library of one or more member molecules, wherein each member of said second library is attached to a second support having attached thereto or embedded therein one or more second populations of semiconductor nanocrystals, each second population having a distinct characteristic second spectral emission, and wherein the second spectral emission is distinct from the first spectral emission;
contacting said first library of molecules with said second library of molecules observing the first and second spectral emissions, wherein said first and second spectral emissions provide information about which of the molecules from the second library of molecules are associated with said first library of molecules, and provides information about the identity of the molecule from said first library of molecules.
29. The method of claim 28, wherein the first library of molecules and the second library of molecules are both proteins, oligonucleotides or sugar moieties.
30. The method of claim 28, wherein the first support is a first bead and second support is a second bead.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10104698P | 1998-09-18 | 1998-09-18 | |
US60/101,046 | 1998-09-18 | ||
US09/160,458 | 1998-09-24 | ||
US09/160,458 US6617583B1 (en) | 1998-09-18 | 1998-09-24 | Inventory control |
PCT/US1999/021373 WO2000017103A2 (en) | 1998-09-18 | 1999-09-17 | Inventory control |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2344145A1 true CA2344145A1 (en) | 2000-03-30 |
CA2344145C CA2344145C (en) | 2010-07-13 |
Family
ID=26797841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2344145A Expired - Lifetime CA2344145C (en) | 1998-09-18 | 1999-09-17 | Inventory control |
Country Status (3)
Country | Link |
---|---|
US (5) | US6617583B1 (en) |
AU (1) | AU1092300A (en) |
CA (1) | CA2344145C (en) |
Families Citing this family (224)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020084329A1 (en) * | 1997-07-16 | 2002-07-04 | Kaye Paul H. | Coded items for labeling objects |
US6607829B1 (en) | 1997-11-13 | 2003-08-19 | Massachusetts Institute Of Technology | Tellurium-containing nanocrystalline materials |
US6207392B1 (en) | 1997-11-25 | 2001-03-27 | The Regents Of The University Of California | Semiconductor nanocrystal probes for biological applications and process for making and using such probes |
US6617583B1 (en) * | 1998-09-18 | 2003-09-09 | Massachusetts Institute Of Technology | Inventory control |
US6263104B1 (en) * | 1998-12-31 | 2001-07-17 | Mcgrew Stephen P. | Method and apparatus for reading and verifying holograms |
CA2403708A1 (en) * | 2000-03-22 | 2001-09-27 | Quantum Dot Corporation | Methods of using semiconductor nanocrystals in bead-based nucleic acid assays |
US6734420B2 (en) * | 2000-04-06 | 2004-05-11 | Quantum Dot Corporation | Differentiable spectral bar code methods and systems |
US20050059031A1 (en) * | 2000-10-06 | 2005-03-17 | Quantum Dot Corporation | Method for enhancing transport of semiconductor nanocrystals across biological membranes |
EP2085781B2 (en) * | 2000-10-06 | 2020-03-11 | Life Technologies Corporation | Transfectable micelles containing semiconductor nanocrystals |
US20020110180A1 (en) * | 2001-02-09 | 2002-08-15 | Barney Alfred A. | Temperature-sensing composition |
JP4681749B2 (en) * | 2001-03-28 | 2011-05-11 | キヤノン株式会社 | Probe carrier management method, probe carrier manufacturing apparatus, and probe carrier management apparatus |
US7153703B2 (en) * | 2001-05-14 | 2006-12-26 | Board Of Trustees Of The University Of Arkansas N. A. | Synthesis of stable colloidal nanocrystals using organic dendrons |
JP2003028797A (en) * | 2001-07-11 | 2003-01-29 | Hitachi Software Eng Co Ltd | Fluorescence reader |
US6869545B2 (en) * | 2001-07-30 | 2005-03-22 | The Board Of Trustees Of The University Of Arkansas | Colloidal nanocrystals with high photoluminescence quantum yields and methods of preparing the same |
US20030062422A1 (en) * | 2001-09-10 | 2003-04-03 | Fateley William G. | System and method for encoded spatio-spectral information processing |
US7150910B2 (en) * | 2001-11-16 | 2006-12-19 | Massachusetts Institute Of Technology | Nanocrystal structures |
US7365840B2 (en) * | 2001-12-28 | 2008-04-29 | Shinya Fukui | Information presenting substance-containing material, and identification method, identification system and device therefor |
US20040026684A1 (en) * | 2002-04-02 | 2004-02-12 | Nanosys, Inc. | Nanowire heterostructures for encoding information |
AU2003231033A1 (en) * | 2002-04-22 | 2003-11-11 | The Code Corporation | Systems and methods for facilitating automatic completion of an electronic form |
JP2006502232A (en) * | 2002-08-15 | 2006-01-19 | モウンギ ジー. バウエンディ | Stabilized semiconductor nanocrystals |
JP5065572B2 (en) * | 2002-09-06 | 2012-11-07 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | Method for verifying fluid movement |
US20040114491A1 (en) * | 2002-09-19 | 2004-06-17 | Demetri Psaltis | High density optical data storage |
WO2004031732A2 (en) | 2002-10-03 | 2004-04-15 | The Board Of Trustees Of The University Of Arkansas | Nanocrystals in ligand boxes exhibiting enhanced chemical, photochemical, and thermal stability, and methods of making the same |
US7192780B2 (en) * | 2002-10-23 | 2007-03-20 | Evident Technologies | Fluorescent lifetime biological detection and imaging using water-stable semiconductor nanocrystals |
US6872450B2 (en) * | 2002-10-23 | 2005-03-29 | Evident Technologies | Water-stable photoluminescent semiconductor nanocrystal complexes and method of making same |
GB0225290D0 (en) * | 2002-10-30 | 2002-12-11 | Secretary Trade Ind Brit | Anti-counterfeiting apparatus and method |
US7056471B1 (en) * | 2002-12-16 | 2006-06-06 | Agency For Science Technology & Research | Ternary and quarternary nanocrystals, processes for their production and uses thereof |
US6863825B2 (en) | 2003-01-29 | 2005-03-08 | Union Oil Company Of California | Process for removing arsenic from aqueous streams |
JP4181435B2 (en) * | 2003-03-31 | 2008-11-12 | 日油株式会社 | Polyethylene glycol modified semiconductor fine particles, production method thereof, and biological diagnostic materials |
US20040252488A1 (en) * | 2003-04-01 | 2004-12-16 | Innovalight | Light-emitting ceiling tile |
US7917298B1 (en) | 2003-04-17 | 2011-03-29 | Nanosys, Inc. | Nanocrystal taggants |
US8859000B2 (en) * | 2003-05-05 | 2014-10-14 | The Research Foundation Of State University Of New York | Synthesis of nanoparticles by an emulsion-gas contacting process |
US7077329B2 (en) * | 2003-06-24 | 2006-07-18 | National Research Council Of Canada | Spectral coding by fluorescent semiconductor nanocrystals for document identification and security applications |
US8796030B2 (en) | 2003-07-12 | 2014-08-05 | Parallel Synthesis Technologies, Inc. | Methods for optically encoding an object with upconverting materials and compositions used therein |
US7044376B2 (en) * | 2003-07-23 | 2006-05-16 | Eastman Kodak Company | Authentication method and apparatus for use with compressed fluid printed swatches |
US7229497B2 (en) * | 2003-08-26 | 2007-06-12 | Massachusetts Institute Of Technology | Method of preparing nanocrystals |
US7422790B1 (en) * | 2003-09-04 | 2008-09-09 | Nanosys, Inc. | Methods of processing nanocrystals, and compositions, devices and systems including same |
US7317521B2 (en) * | 2003-09-18 | 2008-01-08 | Micron Technology, Inc. | Particle detection method |
KR100697511B1 (en) | 2003-10-21 | 2007-03-20 | 삼성전자주식회사 | Photocurable Semiconductor Nanocrystal, Photocurable Composition for Pattern Formation of Semiconductor Nanocrystal and Method of Patterning Nanocrystal using the same |
AU2003285133A1 (en) * | 2003-11-05 | 2005-06-24 | The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services | Biofunctionalized quantum dots for biological imaging |
US20050147977A1 (en) * | 2003-12-29 | 2005-07-07 | Tae-Woong Koo | Methods and compositions for nucleic acid detection and sequence analysis |
US7645397B2 (en) * | 2004-01-15 | 2010-01-12 | Nanosys, Inc. | Nanocrystal doped matrixes |
WO2005067524A2 (en) * | 2004-01-15 | 2005-07-28 | Nanosys, Inc. | Nanocrystal doped matrixes |
US7972437B2 (en) * | 2004-03-22 | 2011-07-05 | The Regents Of The University Of California | Hollow nanocrystals and method of making |
WO2006071247A2 (en) * | 2004-03-30 | 2006-07-06 | California Institute Of Technology | Diagnostic assays including multiplexed lateral flow immunoassays with quantum dots |
US20080032420A1 (en) * | 2004-03-30 | 2008-02-07 | Lambert James L | Surface Enhanced Raman Scattering and Multiplexed Diagnostic Assays |
US7746681B2 (en) | 2005-01-07 | 2010-06-29 | Invisage Technologies, Inc. | Methods of making quantum dot films |
WO2005101530A1 (en) | 2004-04-19 | 2005-10-27 | Edward Sargent | Optically-regulated optical emission using colloidal quantum dot nanocrystals |
US7742322B2 (en) | 2005-01-07 | 2010-06-22 | Invisage Technologies, Inc. | Electronic and optoelectronic devices with quantum dot films |
US7773404B2 (en) | 2005-01-07 | 2010-08-10 | Invisage Technologies, Inc. | Quantum dot optical devices with enhanced gain and sensitivity and methods of making same |
WO2005111926A1 (en) * | 2004-05-18 | 2005-11-24 | Silverbrook Research Pty Ltd | Method and apparatus for security document tracking |
US7552091B2 (en) * | 2004-06-04 | 2009-06-23 | Endicott Interconnect Technologies, Inc. | Method and system for tracking goods |
US7142121B2 (en) | 2004-06-04 | 2006-11-28 | Endicott Interconnect Technologies, Inc. | Radio frequency device for tracking goods |
US7229690B2 (en) * | 2004-07-26 | 2007-06-12 | Massachusetts Institute Of Technology | Microspheres including nanoparticles |
US7557028B1 (en) | 2004-07-28 | 2009-07-07 | Nanosys, Inc. | Process for group III-V semiconductor nanostructure synthesis and compositions made using same |
US7405002B2 (en) | 2004-08-04 | 2008-07-29 | Agency For Science, Technology And Research | Coated water-soluble nanoparticles comprising semiconductor core and silica coating |
US7750352B2 (en) * | 2004-08-10 | 2010-07-06 | Pinion Technologies, Inc. | Light strips for lighting and backlighting applications |
US7794600B1 (en) | 2004-08-27 | 2010-09-14 | Nanosys, Inc. | Purification of nanocrystal solutions by chromatography |
WO2006033396A1 (en) * | 2004-09-22 | 2006-03-30 | Japan Science And Technology Agency | Water-soluble fluorescent material and method for producing same |
US20060240227A1 (en) * | 2004-09-23 | 2006-10-26 | Zhijun Zhang | Nanocrystal coated surfaces |
US7316967B2 (en) * | 2004-09-24 | 2008-01-08 | Massachusetts Institute Of Technology | Flow method and reactor for manufacturing noncrystals |
US7534489B2 (en) * | 2004-09-24 | 2009-05-19 | Agency For Science, Technology And Research | Coated composites of magnetic material and quantum dots |
US8927892B2 (en) * | 2004-10-22 | 2015-01-06 | Parallel Synthesis Technologies | Rare earth downconverting phosphor compositions for optically encoding objects and methods and apparatus relating to same |
US20060196375A1 (en) * | 2004-10-22 | 2006-09-07 | Seth Coe-Sullivan | Method and system for transferring a patterned material |
US7682782B2 (en) * | 2004-10-29 | 2010-03-23 | Affymetrix, Inc. | System, method, and product for multiple wavelength detection using single source excitation |
US20060240590A1 (en) * | 2004-11-09 | 2006-10-26 | The Research Foundation Of State University Of New York | Controlled synthesis of nanowires, nanodiscs, and nanostructured materials using liquid crystalline templates |
US8891575B2 (en) * | 2004-11-30 | 2014-11-18 | Massachusetts Institute Of Technology | Optical feedback structures and methods of making |
JP2008524600A (en) * | 2004-12-16 | 2008-07-10 | インヴィトロジェン コーポレーション | Quantum dot-encoded bead set for multiplex assay calibration and quantification and method of use thereof |
US20060148103A1 (en) * | 2004-12-30 | 2006-07-06 | Yin-Peng Chen | Highly sensitive biological assays |
CA2519608A1 (en) | 2005-01-07 | 2006-07-07 | Edward Sargent | Quantum dot-polymer nanocomposite photodetectors and photovoltaics |
US8134175B2 (en) | 2005-01-11 | 2012-03-13 | Massachusetts Institute Of Technology | Nanocrystals including III-V semiconductors |
US7608237B2 (en) * | 2005-03-28 | 2009-10-27 | The Research Foundation Of State University Of New York | Synthesis of nanostructured materials using liquid crystalline templates |
WO2006119561A1 (en) * | 2005-05-10 | 2006-11-16 | Commonwealth Scientific And Industrial Research Organisation | High-resolution tracking of industrial process materials using trace incorporation of luminescent markers |
US7642086B2 (en) * | 2005-08-09 | 2010-01-05 | Canon Kabushiki Kaisha | Labeled probe bound object, method for producing the same and method for using the same |
US20120157350A1 (en) * | 2005-09-13 | 2012-06-21 | Affymetrix, Inc. | Brownian Microbarcodes for Bioassays |
US20070072309A1 (en) * | 2005-09-29 | 2007-03-29 | General Electric Company | Analytical compositions including nanometer-sized transducers, methods to make thereof, and devices therefrom |
US8673107B2 (en) * | 2005-10-28 | 2014-03-18 | Parallel Synthesis Technologies | Methods for fabricating optically encoded particles and methods for optically encoding objects with such particles |
CA2571904A1 (en) * | 2006-02-15 | 2007-08-15 | Fio Corporation | System and method of detecting pathogens |
US7405402B1 (en) * | 2006-02-21 | 2008-07-29 | Kla-Tencor Technologies Corporation | Method and apparatus for aberration-insensitive electron beam imaging |
US7441704B2 (en) * | 2006-03-03 | 2008-10-28 | Ncr Corporation | System and method for identifying a spatial code |
WO2007143197A2 (en) | 2006-06-02 | 2007-12-13 | Qd Vision, Inc. | Light-emitting devices and displays with improved performance |
US20100119697A1 (en) * | 2006-05-10 | 2010-05-13 | 3M Innovative Properties Company | Compositions and coatings containing fluorescent, inorganic nanoparticles |
US8941299B2 (en) * | 2006-05-21 | 2015-01-27 | Massachusetts Institute Of Technology | Light emitting device including semiconductor nanocrystals |
WO2007143227A2 (en) * | 2006-06-10 | 2007-12-13 | Qd Vision, Inc. | Materials,thin films,optical filters, and devices including same |
US8164087B2 (en) * | 2006-06-12 | 2012-04-24 | Alcatel Lucent | Organic semiconductor compositions with nanoparticles |
US7764361B2 (en) | 2006-07-27 | 2010-07-27 | Northwestern University | Systems and methods to analyze multiplexed bead-based assays using backscattered light |
US8643058B2 (en) * | 2006-07-31 | 2014-02-04 | Massachusetts Institute Of Technology | Electro-optical device including nanocrystals |
US20080042424A1 (en) * | 2006-08-04 | 2008-02-21 | Pitney Bowes Incorporated | Postage stamps having values thereof luminescently encoded thereon and methods of reading such stamps |
WO2008021962A2 (en) | 2006-08-11 | 2008-02-21 | Massachusetts Institute Of Technology | Blue light emitting semiconductor nanocrystals and devices |
US7820009B2 (en) * | 2006-08-18 | 2010-10-26 | The Royal Institution For The Advancement Of Learning/Mcgill University | Cellulose composites comprising hydrophobic particles and their use in paper products |
US8895072B2 (en) * | 2006-09-11 | 2014-11-25 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University | Quantum dot barcode structures and uses thereof |
US7328851B1 (en) † | 2006-10-31 | 2008-02-12 | Xerox Corporation | Machine-readable code format |
WO2008063652A1 (en) | 2006-11-21 | 2008-05-29 | Qd Vision, Inc. | Blue emitting semiconductor nanocrystals and compositions and devices including same |
WO2008063658A2 (en) | 2006-11-21 | 2008-05-29 | Qd Vision, Inc. | Semiconductor nanocrystals and compositions and devices including same |
WO2008133660A2 (en) | 2006-11-21 | 2008-11-06 | Qd Vision, Inc. | Nanocrystals including a group iiia element and a group va element, method, composition, device and other prodcucts |
WO2008063653A1 (en) | 2006-11-21 | 2008-05-29 | Qd Vision, Inc. | Semiconductor nanocrystals and compositions and devices including same |
US8066874B2 (en) | 2006-12-28 | 2011-11-29 | Molycorp Minerals, Llc | Apparatus for treating a flow of an aqueous solution containing arsenic |
US20080274552A1 (en) * | 2007-05-04 | 2008-11-06 | Brian Guthrie | Dynamic Information Transfer |
US20090045360A1 (en) * | 2007-08-13 | 2009-02-19 | Xerox Corporation | Quantum dot-based luminescent marking material |
KR100943839B1 (en) * | 2007-10-31 | 2010-02-24 | 한국과학기술연구원 | Method for the production of bio-imaging nanoparticles with high yield by early introduction of irregular structure |
US8349764B2 (en) | 2007-10-31 | 2013-01-08 | Molycorp Minerals, Llc | Composition for treating a fluid |
US8252087B2 (en) | 2007-10-31 | 2012-08-28 | Molycorp Minerals, Llc | Process and apparatus for treating a gas containing a contaminant |
WO2009145813A1 (en) | 2008-03-04 | 2009-12-03 | Qd Vision, Inc. | Particles including nanoparticles, uses thereof, and methods |
US9525148B2 (en) | 2008-04-03 | 2016-12-20 | Qd Vision, Inc. | Device including quantum dots |
WO2009123763A2 (en) | 2008-04-03 | 2009-10-08 | Qd Vision, Inc. | Light-emitting device including quantum dots |
US20100090164A1 (en) * | 2008-06-10 | 2010-04-15 | Xiaogang Peng | Indium arsenide nanocrystals and methods of making the same |
US9643252B2 (en) | 2008-12-02 | 2017-05-09 | Massachusetts Institute Of Technology | Electrically controlled catalytic nanowire growth based on surface charge density |
NZ595456A (en) | 2009-03-02 | 2012-12-21 | Genia Photonics Inc | Assessing interactions of a sample with light beams having different wavelengths with the use of an intensity modulation function |
US20100264371A1 (en) * | 2009-03-19 | 2010-10-21 | Nick Robert J | Composition including quantum dots, uses of the foregoing, and methods |
KR101783487B1 (en) | 2009-05-01 | 2017-10-23 | 나노시스, 인크. | Functionalized matrixes for dispersion of nanostructures |
JP5561723B2 (en) * | 2009-05-14 | 2014-07-30 | 独立行政法人産業技術総合研究所 | Fluorescent fiber made of semiconductor nanoparticles |
KR101699540B1 (en) * | 2009-07-08 | 2017-01-25 | 삼성전자주식회사 | Semiconductor Nanocrystal and Preparation Method thereof |
DE102009038356A1 (en) * | 2009-08-21 | 2011-03-24 | Bundesdruckerei Gmbh | Security element with color change |
WO2011031876A1 (en) | 2009-09-09 | 2011-03-17 | Qd Vision, Inc. | Formulations including nanoparticles |
KR101865888B1 (en) | 2009-09-09 | 2018-06-08 | 삼성전자주식회사 | Particles including nanoparticles, uses thereof, and methods |
US9425253B2 (en) | 2009-09-23 | 2016-08-23 | Crystalplex Corporation | Passivated nanoparticles |
CN102695500A (en) | 2009-11-09 | 2012-09-26 | 聚光灯技术合伙有限责任公司 | Polysaccharide based hydrogels |
JP2013509963A (en) | 2009-11-09 | 2013-03-21 | スポットライト テクノロジー パートナーズ エルエルシー | Fragmented hydrogel |
JP5838169B2 (en) | 2009-12-31 | 2016-01-06 | ヴェンタナ メディカル システムズ, インク. | Method for generating uniquely specific nucleic acid probes |
EP2539466A4 (en) | 2010-02-26 | 2013-08-07 | Ventana Med Syst Inc | Cytogenic analysis of metaphase chromosomes |
WO2011106583A1 (en) | 2010-02-26 | 2011-09-01 | Ventana Medical Systems, Inc. | Polytag probes |
US8735791B2 (en) | 2010-07-13 | 2014-05-27 | Svv Technology Innovations, Inc. | Light harvesting system employing microstructures for efficient light trapping |
US8587114B2 (en) | 2010-10-05 | 2013-11-19 | International Business Machines Corporation | Multichip electronic packages and methods of manufacture |
CN103534359B (en) | 2011-03-14 | 2016-07-06 | 文塔纳医疗系统公司 | Analyze method and the system thereof of chromosome translocation |
US9233863B2 (en) | 2011-04-13 | 2016-01-12 | Molycorp Minerals, Llc | Rare earth removal of hydrated and hydroxyl species |
CN103649335B (en) | 2011-05-04 | 2015-11-25 | Htg分子诊断有限公司 | Quantitative nucleic acid enzyme protection measures the improvement of (QNPA) and order-checking (QNPS) |
US8508830B1 (en) | 2011-05-13 | 2013-08-13 | Google Inc. | Quantum dot near-to-eye display |
EP2721633B1 (en) * | 2011-06-20 | 2021-05-05 | Crystalplex Corporation | Stabilized nanocrystals |
US9619774B2 (en) | 2011-09-01 | 2017-04-11 | International Business Machines Corporation | Product tracking system |
US9097826B2 (en) | 2011-10-08 | 2015-08-04 | Svv Technology Innovations, Inc. | Collimating illumination systems employing a waveguide |
WO2013057586A1 (en) | 2011-10-19 | 2013-04-25 | Oslo Universitetssykehus Hf | Compositions and methods for producing soluble t - cell receptors |
WO2013108126A2 (en) | 2012-01-16 | 2013-07-25 | University Of Oslo | Methyltransferases and uses thereof |
WO2013167387A1 (en) | 2012-05-10 | 2013-11-14 | Ventana Medical Systems, Inc. | Uniquely specific probes for pten, pik3ca, met, top2a, and mdm2 |
US9139770B2 (en) | 2012-06-22 | 2015-09-22 | Nanosys, Inc. | Silicone ligands for stabilizing quantum dot films |
TWI596188B (en) | 2012-07-02 | 2017-08-21 | 奈米系統股份有限公司 | Highly luminescent nanostructures and methods of producing same |
EP2872646B1 (en) | 2012-07-12 | 2017-08-30 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Methods for predicting the survival time and treatment responsiveness of a patient suffering from a solid cancer with a signature of at least 7 genes |
WO2014031902A2 (en) * | 2012-08-23 | 2014-02-27 | The Regents Of The University Of California | Spectrally encoded microbeads and methods and devices for making and using same |
WO2014048942A1 (en) | 2012-09-25 | 2014-04-03 | Ventana Medical Systems, Inc. | Probes for pten, pik3ca, met, and top2a, and method for using the probes |
CN105247010B (en) | 2013-03-14 | 2017-10-24 | 纳米系统公司 | Solvent-free quantum dot exchange method |
WO2015036405A1 (en) | 2013-09-10 | 2015-03-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for diagnosing and treating basal cell carcinoma |
US10002214B2 (en) | 2013-10-29 | 2018-06-19 | University Of Southern California | Host materials and ligands for dopants in organic light emitting diodes |
US20160265036A1 (en) | 2013-11-05 | 2016-09-15 | Htg Molecular Diagnostics, Inc. | Methods for detecting nucleic acids |
JP6825915B2 (en) | 2014-02-24 | 2021-02-03 | ヴェンタナ メディカル システムズ, インク. | Automatic RNA detection using a labeled 2'-O-methyl RNA oligonucleotide probe and signal amplification system |
MX370462B (en) | 2014-03-07 | 2019-12-13 | Secure Natural Resources Llc | Cerium (iv) oxide with exceptional arsenic removal properties. |
CA2949556C (en) | 2014-05-29 | 2023-03-21 | Crystalplex Corporation | Dispersion system for quantum dots |
EP3009147A1 (en) | 2014-10-16 | 2016-04-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for treating resistant glioblastoma |
US9902802B2 (en) * | 2014-12-08 | 2018-02-27 | Raytheon Company | Zinc sulfide coupling agents |
JP2018502567A (en) | 2015-01-12 | 2018-02-01 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Diagnosis method of pancreatic cancer |
EP3317624B1 (en) | 2015-07-05 | 2019-08-07 | The Whollysee Ltd. | Optical identification and characterization system and tags |
CN106355102B (en) * | 2015-07-15 | 2019-04-02 | 首都师范大学 | Based on nano material and binary double code key symmetric encryption methods with composite signal |
WO2017029391A1 (en) | 2015-08-20 | 2017-02-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New method for treating cancer |
WO2017055319A1 (en) | 2015-09-29 | 2017-04-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for quantifying the population of b cells in a tissue sample |
WO2017055327A1 (en) | 2015-09-29 | 2017-04-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for quantifying the population of endothelial cells in a tissue sample |
WO2017055320A1 (en) | 2015-09-29 | 2017-04-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for quantifying the population of cytotoxic lymphocytes in a tissue sample |
WO2017055322A1 (en) | 2015-09-29 | 2017-04-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for quantifying the population of neutrophils in a tissue sample |
WO2017055325A1 (en) | 2015-09-29 | 2017-04-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for quantifying the population of nk cells in a tissue sample |
WO2017055326A1 (en) | 2015-09-29 | 2017-04-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for quantifying the population of myeloid dendritic cells in a tissue sample |
WO2017055321A1 (en) | 2015-09-29 | 2017-04-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for quantifying the population of fibroblasts in a tissue sample |
WO2017055324A1 (en) | 2015-09-29 | 2017-04-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for quantifying the population of cells of monocytic origin in a tissue sample |
WO2017060397A1 (en) | 2015-10-09 | 2017-04-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the survival time of subjects suffering from melanoma metastases |
WO2017067944A1 (en) | 2015-10-19 | 2017-04-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the survival time of subjects suffering from triple negative breast cancer |
RU2743169C2 (en) | 2015-11-06 | 2021-02-15 | Вентана Медикал Системз, Инк. | Representative diagnosis |
WO2017081073A1 (en) | 2015-11-10 | 2017-05-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the survival time of patients with decompensated alcoholic cirrhosis |
US10760135B2 (en) | 2016-01-13 | 2020-09-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for predicting pancreatic cancer treatment response |
WO2017182834A1 (en) | 2016-04-19 | 2017-10-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New method for treating resistant glioblastoma |
JP7175265B2 (en) | 2016-05-19 | 2022-11-18 | クリスタルプレックス コーポレーション | Cadmium-Free Quantum Dots, Tunable Quantum Dots, Quantum Dot-Containing Polymers, Articles, Films, and 3D Structures Containing Them and Methods of Making and Using Them |
US20190292259A1 (en) | 2016-05-24 | 2019-09-26 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of non small cell lung cancer (nsclc) that coexists with chronic obstructive pulmonary disease (copd) |
US11060147B2 (en) | 2016-06-14 | 2021-07-13 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for predicting acute severe colitis treatment response |
WO2018011107A1 (en) | 2016-07-11 | 2018-01-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of er-alpha 46 in methods and kits for assessing the status of breast cancer |
WO2018011166A2 (en) | 2016-07-12 | 2018-01-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for quantifying the population of myeloid dendritic cells in a tissue sample |
WO2018046738A1 (en) | 2016-09-12 | 2018-03-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the survival time of patients suffering from cancer |
WO2018046736A1 (en) | 2016-09-12 | 2018-03-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the survival time of patients suffering from cancer |
WO2018054960A1 (en) | 2016-09-21 | 2018-03-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting and treating resistance to chemotherapy in npm-alk(+) alcl |
WO2018055080A1 (en) | 2016-09-22 | 2018-03-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for reprograming immune environment in a subject in need thereof |
WO2018122249A1 (en) | 2016-12-28 | 2018-07-05 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the survival time of patients suffering from a microsatellite stable colorectal cancer |
WO2018122245A1 (en) | 2016-12-28 | 2018-07-05 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of predicting the survival time of patients suffering from cms3 colorectal cancer |
WO2018146239A1 (en) | 2017-02-10 | 2018-08-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Biomarker for outcome in aml patients |
WO2018162404A1 (en) | 2017-03-06 | 2018-09-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Biomarker for outcome in aml patients |
WO2018172540A1 (en) | 2017-03-24 | 2018-09-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method to predict the progression of alzheimer's disease |
US11230736B2 (en) | 2017-03-29 | 2022-01-25 | Inserm (Institut National De La Santé De La Recherche Médicale) | Methods for assessing pregnancy outcome |
WO2018189215A1 (en) | 2017-04-12 | 2018-10-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for predicting the survival time of a patient suffering from hepatocellular carcinoma |
WO2019038219A1 (en) | 2017-08-21 | 2019-02-28 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New prognostic method of pancreatic cancer |
WO2019043138A1 (en) | 2017-09-01 | 2019-03-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for predicting the outcome of a cancer |
WO2019092269A1 (en) | 2017-11-13 | 2019-05-16 | F. Hoffmann-La Roche Ag | Devices for sample analysis using epitachophoresis |
WO2019207030A1 (en) | 2018-04-26 | 2019-10-31 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting a response with an immune checkpoint inhibitor in a patient suffering from a lung cancer |
US11946864B2 (en) * | 2018-04-30 | 2024-04-02 | Institut Pasteur De Dakar | Nano encoding technology for the tracking of information in liquid samples |
WO2019229489A1 (en) | 2018-05-31 | 2019-12-05 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of mir-146a-5p and mir-186 as biomarkers of osteoarthritis |
WO2020089432A1 (en) | 2018-11-02 | 2020-05-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New prognostic method of pancreatic cancer |
WO2020089428A1 (en) | 2018-11-02 | 2020-05-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New prognostic method of pancreatic cancer |
KR20220008253A (en) | 2019-01-03 | 2022-01-20 | 엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔 (인쎄름) | Methods and pharmaceutical compositions for enhancing CD8+ T cell dependent immune response in a subject suffering from cancer |
JP2022522265A (en) | 2019-01-16 | 2022-04-15 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Erythroferrone mutants and their use |
EP3924520A1 (en) | 2019-02-13 | 2021-12-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for selecting a cancer treatment in a subject suffering from cancer |
WO2020182932A1 (en) | 2019-03-13 | 2020-09-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New gene signatures for predicting survival time in patients suffering from renal cell carcinoma |
WO2020193740A1 (en) | 2019-03-28 | 2020-10-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New strategy for treating pancreatic cancer |
US20220177978A1 (en) | 2019-04-02 | 2022-06-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of predicting and preventing cancer in patients having premalignant lesions |
WO2020212586A1 (en) | 2019-04-18 | 2020-10-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment and prognosis of cancer |
JP2022530390A (en) | 2019-04-24 | 2022-06-29 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Methods for Predicting Antipsychotic Responses |
EP3969583A1 (en) | 2019-05-14 | 2022-03-23 | F. Hoffmann-La Roche AG | Devices and methods for sample analysis |
WO2020229521A1 (en) | 2019-05-14 | 2020-11-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for inhibiting or reducing bacterial biofilms on a surface |
WO2021001539A1 (en) | 2019-07-04 | 2021-01-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New strategy to detect and treat eosinophilic fasciitis |
WO2021044012A1 (en) | 2019-09-05 | 2021-03-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method of treatment and pronostic of acute myeloid leukemia |
WO2021063968A1 (en) | 2019-09-30 | 2021-04-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method and composition for diagnosing chronic obstructive pulmonary disease |
WO2021074391A1 (en) | 2019-10-17 | 2021-04-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for diagnosing nasal intestinal type adenocarcinomas |
US20230113705A1 (en) | 2020-02-28 | 2023-04-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for diagnosing, prognosing and managing treatment of breast cancer |
WO2021186014A1 (en) | 2020-03-20 | 2021-09-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for predicting the survival time of a patient suffering from a cancer |
CN113691426B (en) * | 2020-05-19 | 2023-08-18 | 中国电子科技集团公司第十一研究所 | Network access method and device |
US20230250426A1 (en) | 2020-06-10 | 2023-08-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for treating and prognosing cancer like glioblastoma |
EP4168006A1 (en) | 2020-06-18 | 2023-04-26 | Institut National de la Santé et de la Recherche Médicale (INSERM) | New strategy for treating pancreatic cancer |
WO2022018163A1 (en) | 2020-07-22 | 2022-01-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for predicting survival time in patients suffering from cancer |
WO2022064049A1 (en) | 2020-09-28 | 2022-03-31 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for diagnosing brucella infection |
US20230383350A1 (en) | 2020-10-20 | 2023-11-30 | Institut National De La Sante Et De La Recherche Medicale | Method for predicting the response to tnf inhibitors |
US20240011094A1 (en) | 2020-11-06 | 2024-01-11 | Institut National de la Santé et de la Recherche Médicale | Methods for diagnosis and treating polycystic ovary syndrome (pcos) |
WO2022136252A1 (en) | 2020-12-21 | 2022-06-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for prognosis the humoral response of a subject prior to vaccination |
WO2022135753A1 (en) | 2020-12-21 | 2022-06-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for prognosis the humoral response of a subject prior to vaccination |
WO2022152698A1 (en) | 2021-01-12 | 2022-07-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of npdk-d to evaluate cancer prognosis |
WO2022171611A1 (en) | 2021-02-09 | 2022-08-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New method to pronostic lung cancer |
WO2022194949A1 (en) | 2021-03-17 | 2022-09-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for diagnosing pancreatic cancer |
WO2022207566A1 (en) | 2021-03-29 | 2022-10-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New method to evaluate pancreatic cancer prognosis |
WO2022223791A1 (en) | 2021-04-23 | 2022-10-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for treating cell senescence accumulation related disease |
WO2023280790A1 (en) | 2021-07-05 | 2023-01-12 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Gene signatures for predicting survival time in patients suffering from renal cell carcinoma |
WO2023089159A1 (en) | 2021-11-22 | 2023-05-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New strategy targeting stroma/tumor cell crosstalk to treat a cancer |
WO2023144303A1 (en) | 2022-01-31 | 2023-08-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Cd38 as a biomarker and biotarget in t-cell lymphomas |
WO2023152133A1 (en) | 2022-02-08 | 2023-08-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for diagnosing colorectal cancer |
WO2024061930A1 (en) | 2022-09-22 | 2024-03-28 | Institut National de la Santé et de la Recherche Médicale | New method to treat and diagnose peripheral t-cell lymphoma (ptcl) |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US3989814A (en) * | 1975-01-28 | 1976-11-02 | Colgate-Palmolive Company | Calcium pyrophosphate abrasive system for dentifrice |
US4637988A (en) | 1981-07-01 | 1987-01-20 | Eastman Kodak Company | Fluorescent labels for immunoassay |
US4717655A (en) * | 1982-08-30 | 1988-01-05 | Becton, Dickinson And Company | Method and apparatus for distinguishing multiple subpopulations of cells |
US4777128A (en) | 1986-05-27 | 1988-10-11 | Ethigen Corporation | Fluorescence immunoassay involving energy transfer between two fluorophores |
US5304786A (en) | 1990-01-05 | 1994-04-19 | Symbol Technologies, Inc. | High density two-dimensional bar code symbol |
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
AU669489B2 (en) * | 1991-09-18 | 1996-06-13 | Affymax Technologies N.V. | Method of synthesizing diverse collections of oligomers |
EP0613585A4 (en) | 1991-11-22 | 1995-06-21 | Univ California | Semiconductor nanocrystals covalently bound to solid inorganic surfaces using self-assembled monolayers. |
US5505928A (en) | 1991-11-22 | 1996-04-09 | The Regents Of University Of California | Preparation of III-V semiconductor nanocrystals |
US5262357A (en) | 1991-11-22 | 1993-11-16 | The Regents Of The University Of California | Low temperature thin films formed from nanocrystal precursors |
US5515393A (en) | 1992-01-29 | 1996-05-07 | Sony Corporation | Semiconductor laser with ZnMgSSe cladding layers |
RU94046132A (en) | 1992-05-22 | 1996-09-27 | Миннесота Майнинг энд Мануфакчуринг Компани (US) | Method for controlling molecular beam epitaxial system in manufacturing electric fluorescent devices around semiconductor compound ii-vi and laser diodes ii-vi |
US6399397B1 (en) * | 1992-09-14 | 2002-06-04 | Sri International | Up-converting reporters for biological and other assays using laser excitation techniques |
US5674698A (en) | 1992-09-14 | 1997-10-07 | Sri International | Up-converting reporters for biological and other assays using laser excitation techniques |
US5565324A (en) | 1992-10-01 | 1996-10-15 | The Trustees Of Columbia University In The City Of New York | Complex combinatorial chemical libraries encoded with tags |
US5721099A (en) | 1992-10-01 | 1998-02-24 | Trustees Of Columbia University In The City Of New York | Complex combinatorial chemical libraries encoded with tags |
US5254707A (en) * | 1992-12-07 | 1993-10-19 | Ethyl Corporation | Preparation of cyclopentadiene derivatives |
US5308804A (en) * | 1992-12-15 | 1994-05-03 | Lee Huai Chuan | Moving disks made of semiconductor nanocrystallite embedded glass |
US5295791A (en) * | 1993-01-19 | 1994-03-22 | Meise William H | Tapered fluid compressor & refrigeration apparatus |
US5293050A (en) | 1993-03-25 | 1994-03-08 | International Business Machines Corporation | Semiconductor quantum dot light emitting/detecting devices |
US6048616A (en) | 1993-04-21 | 2000-04-11 | Philips Electronics N.A. Corp. | Encapsulated quantum sized doped semiconductor particles and method of manufacturing same |
JPH0750448A (en) | 1993-08-04 | 1995-02-21 | Matsushita Electric Ind Co Ltd | Semiconductor laser and manufacture thereof |
US5492080A (en) | 1993-12-27 | 1996-02-20 | Matsushita Electric Industrial Co., Ltd. | Crystal-growth method and semiconductor device production method using the crystal-growth method |
US5422489A (en) | 1994-01-24 | 1995-06-06 | Bhargava; Rameshwar N. | Light emitting device |
US5881886A (en) | 1994-03-18 | 1999-03-16 | Brown University Research Foundation | Optically-based methods and apparatus for sorting garments and other textiles |
US5448582A (en) | 1994-03-18 | 1995-09-05 | Brown University Research Foundation | Optical sources having a strongly scattering gain medium providing laser-like action |
GB2318666B (en) | 1994-04-25 | 1998-07-15 | Univ Hertfordshire | Coded items for labelling objects |
US5537000A (en) | 1994-04-29 | 1996-07-16 | The Regents, University Of California | Electroluminescent devices formed using semiconductor nanocrystals as an electron transport media and method of making such electroluminescent devices |
US5541948A (en) | 1994-11-28 | 1996-07-30 | The Regents Of The University Of California | Transition-metal doped sulfide, selenide, and telluride laser crystal and lasers |
US5985353A (en) | 1994-12-01 | 1999-11-16 | University Of Massachusetts Lowell | Biomolecular synthesis of quantum dot composites |
US5585640A (en) | 1995-01-11 | 1996-12-17 | Huston; Alan L. | Glass matrix doped with activated luminescent nanocrystalline particles |
US5747180A (en) | 1995-05-19 | 1998-05-05 | University Of Notre Dame Du Lac | Electrochemical synthesis of quasi-periodic quantum dot and nanostructure arrays |
US5736330A (en) | 1995-10-11 | 1998-04-07 | Luminex Corporation | Method and compositions for flow cytometric determination of DNA sequences |
DE19541028C2 (en) | 1995-11-05 | 1998-01-22 | Daimler Benz Ag | Effect varnish with pigments bearing a label, and process for its production |
US6361944B1 (en) * | 1996-07-29 | 2002-03-26 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
CA2262018C (en) | 1996-07-29 | 2007-10-02 | Nanosphere Llc | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US5908608A (en) | 1996-11-08 | 1999-06-01 | Spectra Science Corporation | Synthesis of metal chalcogenide quantum |
US5939021A (en) | 1997-01-23 | 1999-08-17 | Hansen; W. Peter | Homogeneous binding assay |
AU6271798A (en) | 1997-02-18 | 1998-09-08 | Spectra Science Corporation | Field activated security thread including polymer dispersed liquid crystal |
US6096496A (en) * | 1997-06-19 | 2000-08-01 | Frankel; Robert D. | Supports incorporating vertical cavity emitting lasers and tracking apparatus for use in combinatorial synthesis |
KR20010031140A (en) | 1997-10-14 | 2001-04-16 | 루미넥스 코포레이션 | Precision fluorescently dyed particles and methods of making and using same |
US5985173A (en) * | 1997-11-18 | 1999-11-16 | Gray; Henry F. | Phosphors having a semiconductor host surrounded by a shell |
US5990479A (en) * | 1997-11-25 | 1999-11-23 | Regents Of The University Of California | Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes |
US6207392B1 (en) * | 1997-11-25 | 2001-03-27 | The Regents Of The University Of California | Semiconductor nanocrystal probes for biological applications and process for making and using such probes |
US6617583B1 (en) * | 1998-09-18 | 2003-09-09 | Massachusetts Institute Of Technology | Inventory control |
US6251303B1 (en) * | 1998-09-18 | 2001-06-26 | Massachusetts Institute Of Technology | Water-soluble fluorescent nanocrystals |
EP0990903B1 (en) * | 1998-09-18 | 2003-03-12 | Massachusetts Institute Of Technology | Biological applications of semiconductor nanocrystals |
US6326144B1 (en) * | 1998-09-18 | 2001-12-04 | Massachusetts Institute Of Technology | Biological applications of quantum dots |
US6261779B1 (en) | 1998-11-10 | 2001-07-17 | Bio-Pixels Ltd. | Nanocrystals having polynucleotide strands and their use to form dendrimers in a signal amplification system |
US6114038A (en) | 1998-11-10 | 2000-09-05 | Biocrystal Ltd. | Functionalized nanocrystals and their use in detection systems |
US6309701B1 (en) | 1998-11-10 | 2001-10-30 | Bio-Pixels Ltd. | Fluorescent nanocrystal-labeled microspheres for fluorescence analyses |
WO2000027436A1 (en) | 1998-11-10 | 2000-05-18 | Biocrystal Limited | Functionalized nanocrystals as visual tissue-specific imaging agents, and methods for fluorescence imaging |
WO2000028089A1 (en) | 1998-11-10 | 2000-05-18 | Biocrystal Limited | Functionalized nanocrystals and their use in labeling for strand synthesis or sequence determination |
WO2000027365A1 (en) | 1998-11-10 | 2000-05-18 | Biocrystal Limited | Functionalized nanocrystals and their use in detection systems |
ATE439452T1 (en) * | 1999-05-07 | 2009-08-15 | Life Technologies Corp | METHOD FOR DETECTING ANALYTES USING SEMICONDUCTOR NANOCRYSTALS |
US6544732B1 (en) * | 1999-05-20 | 2003-04-08 | Illumina, Inc. | Encoding and decoding of array sensors utilizing nanocrystals |
US6416744B1 (en) * | 2001-06-21 | 2002-07-09 | Colgate Palmolive Company | Tooth whitening chewing gum |
-
1998
- 1998-09-24 US US09/160,458 patent/US6617583B1/en not_active Expired - Lifetime
-
1999
- 1999-09-17 US US09/397,432 patent/US6602671B1/en not_active Expired - Lifetime
- 1999-09-17 AU AU10923/00A patent/AU1092300A/en not_active Abandoned
- 1999-09-17 CA CA2344145A patent/CA2344145C/en not_active Expired - Lifetime
-
2002
- 2002-05-30 US US10/157,232 patent/US6774361B2/en not_active Expired - Lifetime
-
2003
- 2003-08-04 US US10/632,922 patent/US7943552B2/en not_active Expired - Fee Related
-
2004
- 2004-06-02 US US10/858,207 patent/US20040217298A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6617583B1 (en) | 2003-09-09 |
CA2344145C (en) | 2010-07-13 |
US7943552B2 (en) | 2011-05-17 |
US6774361B2 (en) | 2004-08-10 |
US20040038310A1 (en) | 2004-02-26 |
US20040217298A1 (en) | 2004-11-04 |
US20020160412A1 (en) | 2002-10-31 |
US6602671B1 (en) | 2003-08-05 |
AU1092300A (en) | 2000-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2344145A1 (en) | Inventory control | |
US7361516B2 (en) | Field of modular multifunctional ligands | |
EP1266223B1 (en) | Inorganic particle conjugates | |
US7108915B2 (en) | Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media | |
US8362684B2 (en) | Quantum dot white and colored light-emitting devices | |
CN104755586B (en) | The part based on PDMS for the quantum dot in silicone | |
Grabolle et al. | Stability and fluorescence quantum yield of CdSe–ZnS quantum dots—influence of the thickness of the ZnS shell | |
JP2006508012A5 (en) | ||
US20080241963A1 (en) | Biochemical labeling materials and manufacturing method thereof | |
Gharaat et al. | A dextran mediated multicolor immunochromatographic rapid test strip for visual and instrumental simultaneous detection of Vibrio cholera O1 (Ogawa) and Clostridium botulinum toxin A | |
CN112204400A (en) | Quantum dot beads having multifunctional ligand, and target antigen detection method and biological diagnostic device using the same | |
Liu et al. | Bioconjugate recognition molecules to quantum dots as tumor probes | |
Mattoussi et al. | Colloidal semiconductor quantum dot conjugates in biosensing | |
WO2008035565A1 (en) | Biomolecule detection reagent and biomolecule detection method using the same | |
Wilcoxon et al. | Optical properties of II-VI semiconductor nanoclusters for use as phosphors | |
SG178725A1 (en) | Polymer-coated nanoparticles | |
KR20080083699A (en) | Synthesis of alloyed nanocrystals in aqueous or water-soluble solvents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |